About Acadia Healthcare (NASDAQ:ACHC)
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNASDAQ:ACHC
CUSIP00404A10
Phone615-861-6000
Debt
Debt-to-Equity Ratio1.25%
Current Ratio1.25%
Quick Ratio1.25%
Price-To-Earnings
Trailing P/E Ratio17.09
Forward P/E Ratio16.00
P/E Growth1.27
Sales & Book Value
Annual Sales$2.84 billion
Price / Sales1.22
Cash Flow$4.0506 per share
Price / Cash9.68
Book Value$29.29 per share
Price / Book1.34
Profitability
EPS (Most Recent Fiscal Year)$2.30
Net Income$199.83 million
Net Margins6.92%
Return on Equity8.16%
Return on Assets3.15%
Miscellaneous
Employees40,600
Outstanding Shares88,270,000
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare (NASDAQ:ACHC) issued its quarterly earnings data on Wednesday, February, 21st. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.07. The business had revenue of $724.50 million for the quarter, compared to analysts' expectations of $713.20 million. Acadia Healthcare had a return on equity of 8.16% and a net margin of 6.92%. The firm's quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.59 EPS. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
What guidance has Acadia Healthcare issued on next quarter's earnings?
Acadia Healthcare updated its FY18 earnings guidance on Wednesday, February, 21st. The company provided earnings per share (EPS) guidance of $2.42-2.48 for the period, compared to the Thomson Reuters consensus estimate of $2.49. The company issued revenue guidance of $3.04-3.08 billion, compared to the consensus revenue estimate of $3.00 billion.Acadia Healthcare also updated its Q1 guidance to $0.47-0.49 EPS.
What price target have analysts set for ACHC?
16 analysts have issued twelve-month price objectives for Acadia Healthcare's stock. Their predictions range from $36.00 to $60.00. On average, they anticipate Acadia Healthcare's share price to reach $44.50 in the next year. View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 0.8% upward over the last 30 days, which reflects investors' optimism towrads the stock. However, the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are the major headwinds." (2/12/2018)
- 2. Mizuho analysts commented, "fix the U.K. issues away from public scrutiny." The problem is the balance sheet's debt to EBITDA leverage of roughly 5.4x, which serves as a notable obstacle towards a go-private deal.But Acadia's woes are also domestic-based as the Centers for Medicare & Medicaid Services (CMS) proposed on Friday a change to a rule that gives states more flexibility to interpret the ACA's 10 essential benefit requirements — one of which includes mental health."Given the national focus on mental health and addiction, we would be surprised if these benefits are at risk," Hynes also said. "However, it could provide an overhang on an already fragile stock." (10/29/2017)
- 3. Cantor Fitzgerald analysts commented, "3Q17 falls short. ACHC reported 3Q17 adjusted EPS of $0.58 (including $0.02 of costs due to last month’s hurricanes), vs. our $0.64 estimate and the $0.65 FactSet consensus. Adjusted EBITDA was $152.3 million, vs. our $160.8 million estimate and the $163 million consensus." (10/24/2017)
Are investors shorting Acadia Healthcare?
Acadia Healthcare saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 14,310,269 shares, an increase of 15.5% from the March 15th total of 12,390,259 shares. Based on an average daily trading volume, of 1,004,448 shares, the days-to-cover ratio is currently 14.2 days. Approximately 16.7% of the shares of the company are short sold.
Who are some of Acadia Healthcare's key competitors?
Some companies that are related to Acadia Healthcare include West Pharmaceutical Services (WST), ICON (ICLR), Exelixis (EXEL), Stada Arzneimittel (STDAF), Dexcom (DXCM), Valeant Pharmaceuticals International (VRX), athenahealth (ATHN), Hill-Rom (HRC), EXACT Sciences (EXAS), Bio-Techne (TECH), Encompass Health (EHC), PRA Health Sciences (PRAH), Catalent (CTLT), Ionis Pharmaceuticals (IONS), Dr. Reddy's Laboratories (RDY), Stada Arzneimittel (SAZ), ICU Medical (ICUI) and Sarepta Therapeutics (SRPT).
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Joey A. Jacobs, Chairman of the Board, Chief Executive Officer (Age 62)
- W. Brent Turner, President (Age 51)
- Bruce A. Shear, Executive Vice Chairman (Age 62)
- David M. Duckworth, Chief Financial Officer (Age 37)
- Ronald Morgan Fincher, Chief Operating Officer (Age 63)
- Christopher L. Howard, Executive Vice President, General Counsel, Secretary (Age 50)
- Reeve B. Waud Jr., Lead Independent Director (Age 53)
- E. Perot Bissell, Independent Director (Age 57)
- Christopher R. Gordon, Independent Director (Age 44)
- Vicky B. Gregg, Independent Director (Age 62)
Has Acadia Healthcare been receiving favorable news coverage?
News articles about ACHC stock have trended somewhat positive recently, according to Accern. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Acadia Healthcare earned a news impact score of 0.17 on Accern's scale. They also gave press coverage about the company an impact score of 46.37 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $39.41.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $3.43 billion and generates $2.84 billion in revenue each year. The company earns $199.83 million in net income (profit) each year or $2.30 on an earnings per share basis. Acadia Healthcare employs 40,600 workers across the globe.
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Acadia Healthcare (NASDAQ:ACHC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Acadia Healthcare in the last 12 months. Their average twelve-month price target is $44.50, suggesting that the stock has a possible upside of 13.49%. The high price target for ACHC is $60.00 and the low price target for ACHC is $36.00. There are currently 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.69 | 2.69 | 2.57 | 2.92 |
| Ratings Breakdown: | 0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s) |
| Consensus Price Target: | $44.50 | $44.50 | $44.1667 | $57.6364 |
| Price Target Upside: | 13.49% upside | 15.37% upside | 38.63% upside | 30.52% upside |
Acadia Healthcare (NASDAQ:ACHC) Consensus Price Target History
Acadia Healthcare (NASDAQ:ACHC) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Acadia Healthcare (NASDAQ:ACHC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Acadia Healthcare (NASDAQ ACHC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 11.10%
Acadia Healthcare (NASDAQ ACHC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/15/2018 | Reeve B Waud | Director | Sell | 7,698 | $42.03 | $323,546.94 | 10,088 |  |
| 3/14/2018 | Randall P Goldberg | VP | Sell | 400 | $41.47 | $16,588.00 | 5,757 | |
| 3/13/2018 | Reeve B Waud | Director | Sell | 42,302 | $42.02 | $1,777,530.04 | 10,088 | |
| 3/6/2018 | Reeve B Waud | Director | Sell | 200,000 | $39.02 | $7,804,000.00 | 10,088 | |
| 3/2/2018 | Reeve B Waud | Director | Sell | 150,000 | $38.67 | $5,800,500.00 | 10,088 | |
| 3/1/2018 | Randall P Goldberg | VP | Sell | 960 | $38.47 | $36,931.20 | 6,942 | |
| 12/15/2017 | Reeve B. Waud | Director | Sell | 100,000 | $31.80 | $3,180,000.00 | | |
| 8/22/2017 | Brent Turner | President | Sell | 206,252 | $50.69 | $10,454,913.88 | 81,106 | |
| 8/22/2017 | Christopher L Howard | EVP | Sell | 53,713 | $50.69 | $2,722,711.97 | 147,286 | |
| 8/22/2017 | Joey A Jacobs | CEO | Sell | 500,000 | $50.69 | $25,345,000.00 | 201,496 | |
| 8/22/2017 | Reeve B. Waud | Director | Sell | 984,075 | $50.69 | $49,882,761.75 | | |
| 8/22/2017 | Ronald Morgan Fincher | COO | Sell | 80,000 | $50.69 | $4,055,200.00 | 59,071 | |
| 8/11/2017 | William Grieco | Director | Sell | 2,000 | $51.71 | $103,420.00 | 45,013 | |
| 8/3/2017 | Christopher L Howard | EVP | Sell | 16,762 | $52.47 | $879,502.14 | 200,999 | |
| 7/31/2017 | Reeve B. Waud | Director | Sell | 1,240,000 | $51.72 | $64,132,800.00 | | |
| 7/31/2017 | Scott Schwieger | Insider | Sell | 2,891 | $52.85 | $152,789.35 | 8,841 | |
| 7/5/2017 | Reeve B. Waud | Director | Sell | 50,000 | $50.04 | $2,502,000.00 | | |
| 6/22/2017 | Reeve B. Waud | Director | Sell | 50,000 | $47.51 | $2,375,500.00 | | |
| 6/16/2017 | William Grieco | Director | Sell | 2,000 | $45.42 | $90,840.00 | 47,013 | |
| 6/14/2017 | Reeve B. Waud | Director | Sell | 724,694 | $45.53 | $32,995,317.82 | | |
| 6/9/2017 | Reeve B. Waud | Director | Sell | 50,000 | $45.09 | $2,254,500.00 | | |
| 5/4/2017 | Randall P Goldberg | VP | Sell | 4,925 | $45.18 | $222,511.50 | 10,607 | |
| 5/1/2017 | Ronald Morgan Fincher | COO | Sell | 86,483 | $44.43 | $3,842,439.69 | 137,204 | |
| 3/8/2017 | Randall P Goldberg | VP | Sell | 914 | $43.55 | $39,804.70 | 7,376 | |
| 12/16/2016 | Reeve B Waud | Director | Sell | 28,000 | $34.58 | $968,240.00 | 55,673 | |
| 12/14/2016 | Reeve B Waud | Director | Sell | 42,000 | $34.71 | $1,457,820.00 | 55,673 | |
| 12/13/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.10 | $491,400.00 | 55,673 | |
| 12/12/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.79 | $501,060.00 | 55,673 | |
| 9/16/2016 | Reeve B Waud | Director | Sell | 1,360,977 | $48.52 | $66,034,604.04 | 55,673 | |
| 9/16/2016 | Waud Capital Partners Iii, L.L | Major Shareholder | Sell | 457,443 | $48.39 | $22,135,666.77 | | |
| 9/13/2016 | Reeve B Waud | Director | Sell | 84,208 | $51.71 | $4,354,395.68 | 55,673 | |
| 9/13/2016 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 54,254 | $51.71 | $2,805,474.34 | | |
| 8/15/2016 | David M Duckworth | CFO | Sell | 16,670 | $54.33 | $905,681.10 | 11,688 | |
| 8/12/2016 | Ronald Morgan Fincher | COO | Sell | 14,604 | $52.50 | $766,710.00 | 110,780 | |
| 8/8/2016 | Ronald Morgan Fincher | COO | Sell | 8,800 | $52.56 | $462,528.00 | 120,780 | |
| 11/6/2015 | Danny E Carpenter | Major Shareholder | Sell | 15,000 | $74.02 | $1,110,300.00 | 48,384 | |
| 8/14/2015 | Bain Capital Investors Llc | Insider | Sell | 2,351,137 | $80.47 | $189,195,994.39 | | |
| 8/14/2015 | Reeve B Waud | Director | Sell | 2,400,001 | $80.47 | $193,128,080.47 | | |
| 8/14/2015 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 1,635,457 | $80.47 | $131,605,224.79 | | |
| 4/2/2015 | Joey A Jacobs | CEO | Sell | 24,277 | $70.06 | $1,700,846.62 | | |
| 3/16/2015 | Robert Walton Swinson | Major Shareholder | Sell | 5,981 | $69.58 | $416,157.98 | | |
| 3/13/2015 | Brent Turner | Major Shareholder | Sell | 11,779 | $69.68 | $820,760.72 | | |
| 2/19/2015 | David M Duckworth | CFO | Sell | 9,504 | $62.31 | $592,194.24 | | |
| 2/19/2015 | Ronald Morgan Fincher | COO | Sell | 10,703 | $62.50 | $668,937.50 | | |
| 2/18/2015 | Christopher L Howard | EVP | Sell | 9,378 | $62.75 | $588,469.50 | | |
| 12/8/2014 | Robert Walton Swinson | Major Shareholder | Sell | 2,500 | $64.25 | $160,625.00 | | |
| 11/6/2014 | Danny E Carpenter | Major Shareholder | Sell | 9,460 | $60.82 | $575,357.20 | | |
| 11/3/2014 | Brent Turner | Major Shareholder | Sell | 35,167 | $60.18 | $2,116,350.06 | | |
| 11/3/2014 | Bruce A Shear | Chairman | Sell | 25,000 | $59.12 | $1,478,000.00 | | |
| 11/3/2014 | Christopher L Howard | EVP | Sell | 29,245 | $59.94 | $1,752,945.30 | | |
| 11/3/2014 | Joey A Jacobs | CEO | Sell | 133,087 | $59.95 | $7,978,565.65 | | |
| 11/3/2014 | Ronald Morgan Fincher | COO | Sell | 29,695 | $60.42 | $1,794,171.90 | | |
| 8/25/2014 | William Grieco | Director | Sell | 4,522 | $50.67 | $229,129.74 | | |
| 8/21/2014 | William Grieco | Director | Sell | 7,000 | $50.33 | $352,310.00 | | |
| 8/13/2014 | David M Duckworth | CFO | Sell | 1,400 | $48.79 | $68,306.00 | | |
| 8/13/2014 | Ronald Morgan Fincher | COO | Sell | 2,489 | $48.00 | $119,472.00 | | |
| 7/29/2014 | Christopher L Howard | EVP | Sell | 1,156 | $51.01 | $58,967.56 | | |
| 7/29/2014 | Jack E Polson | Major Shareholder | Sell | 4,000 | $50.34 | $201,360.00 | | |
| 6/4/2014 | Ronald Morgan Fincher | COO | Sell | 4,442 | $47.68 | $211,794.56 | | |
| 5/2/2014 | Brent Turner | major shareholder | Sell | 24,595 | $45.00 | $1,106,775.00 | 80,163 | |
| 5/2/2014 | Christopher Howard | EVP | Sell | 11,536 | $40.76 | $470,207.36 | 238,001 | |
| 5/2/2014 | Joey Jacobs | CEO | Sell | 19,291 | $45.00 | $868,095.00 | 319,880 | |
| 5/1/2014 | Norman King Carter III | major shareholder | Sell | 10,896 | $42.04 | $458,067.84 | | |
| 4/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $41.73 | $1,251,900.00 | 10,896 | |
| 4/9/2014 | Karen Marie Prince | major shareholder | Sell | 5,579 | $44.09 | $245,978.11 | 100 | |
| 3/14/2014 | Bruce Shear | Chairman | Sell | 38,069 | $46.10 | $1,754,980.90 | 91,486 | |
| 3/14/2014 | David Duckworth | CFO | Sell | 7,540 | $45.73 | $344,804.20 | 29,501 | |
| 3/14/2014 | William Grieco | Director | Sell | 5,000 | $46.29 | $231,450.00 | 36,423 | |
| 2/3/2014 | Norman King Carter III | major shareholder | Sell | 20,000 | $51.08 | $1,021,600.00 | 40,896 | |
| 1/31/2014 | Karen Marie Prince | major shareholder | Sell | 10,000 | $51.42 | $514,200.00 | 5,679 | |
| 1/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $51.79 | $1,553,700.00 | 60,896 | |
| 11/1/2013 | Norman King Carter III | Major Shareholder | Sell | 29,600 | $42.20 | $1,249,120.00 | | |
| 10/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 20,000 | $39.14 | $782,800.00 | | |
| 8/1/2013 | Karen Marie Prince | Major Shareholder | Sell | 28,000 | $35.80 | $1,002,400.00 | | |
| 7/31/2013 | Norman King Carter III | Major Shareholder | Sell | 20,000 | $35.30 | $706,000.00 | | |
| 7/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 22,000 | $34.26 | $753,720.00 | | |
| 6/10/2013 | William Grieco | Director | Sell | 13,000 | $34.77 | $452,010.00 | | |
| 5/15/2013 | Bruce A Shear | Chairman | Sell | 10,000 | $34.50 | $345,000.00 | | |
| 5/10/2013 | William Grieco | Director | Sell | 15,000 | $33.34 | $500,100.00 | | |
| 5/9/2013 | David M Duckworth | CFO | Sell | 4,000 | $33.20 | $132,800.00 | | |
| 5/7/2013 | Ronald Morgan Fincher | COO | Sell | 2,804 | $32.78 | $91,915.12 | | |
| 12/24/2012 | Brent Turner | Major Shareholder | Sell | 10,551 | $21.60 | $227,901.60 | | |
| 12/24/2012 | Bruce A Shear | Chairman | Sell | 7,500 | $21.60 | $162,000.00 | | |
| 12/24/2012 | Christopher L Howard | EVP | Sell | 8,774 | $21.60 | $189,518.40 | | |
| 12/24/2012 | Joey A Jacobs | CEO | Sell | 39,927 | $21.60 | $862,423.20 | | |
| 12/24/2012 | Reeve B Waud | Director | Sell | 425,591 | $21.60 | $9,192,765.60 | | |
| 12/24/2012 | Ronald Morgan Fincher | COO | Sell | 8,909 | $21.60 | $192,434.40 | | |
(Data available from 1/1/2013 forward)
Acadia Healthcare (NASDAQ ACHC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Acadia Healthcare Company, Inc. To Contact The Firm
finance.yahoo.com - April 19 at 8:59 AM |
 | Health care CEO joins Nashville Predators' ownership group
www.bizjournals.com - April 18 at 5:05 PM |
 | Acadia Healthcare (ACHC) Receives New Coverage from Analysts at William Blair
www.americanbankingnews.com - April 17 at 5:54 PM |
| Acadia Healthcare (ACHC) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - April 17 at 10:29 AM |
| BioTelemetry (BEAT) vs. Acadia Healthcare (ACHC) Critical Review
www.americanbankingnews.com - April 16 at 9:19 PM |
| Zacks: Analysts Expect Acadia Healthcare (ACHC) Will Announce Quarterly Sales of $730.09 Million
www.americanbankingnews.com - April 16 at 2:51 AM |
| BioTelemetry (BEAT) & Acadia Healthcare (ACHC) Head-To-Head Survey
www.americanbankingnews.com - April 15 at 1:21 AM |
| Acadia Healthcare (ACHC) Cut to Hold at BidaskClub
www.americanbankingnews.com - April 15 at 12:36 AM |
| Zacks: Brokerages Expect Acadia Healthcare (ACHC) to Post $0.47 EPS
www.americanbankingnews.com - April 14 at 3:11 PM |
| Acadia Healthcare (ACHC) Sees Large Increase in Short Interest
www.americanbankingnews.com - April 13 at 2:10 AM |
| Contrasting Acadia Healthcare (ACHC) & Hanger (HNGR)
www.americanbankingnews.com - April 12 at 11:19 PM |
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Acadia Healthcare Company, Inc. (Nasdaq: ACHC) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - April 9 at 4:46 PM |
| Acadia Healthcare Announces Date for First Quarter 2018 Earnings Release
finance.yahoo.com - April 9 at 4:46 PM |
 | Options Traders Expect Huge Moves in Acadia Healthcare (ACHC) Stock
www.zacks.com - April 9 at 9:12 AM |
| Acadia Healthcare (ACHC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 8 at 2:39 PM |
| ValuEngine Lowers Acadia Healthcare (ACHC) to Sell
www.americanbankingnews.com - April 7 at 10:27 AM |
 | These 5 Stocks Could Be in Big Trouble If Interest Rates Go Higher
www.msn.com - April 7 at 9:28 AM |
 | ACADIA HEALTHCARE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline ...
www.businesswire.com - April 7 at 9:28 AM |
| ACADIA HEALTHCARE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc.
finance.yahoo.com - April 7 at 9:28 AM |
| BidaskClub Upgrades Acadia Healthcare (ACHC) to Strong-Buy
www.americanbankingnews.com - April 7 at 7:02 AM |
| Acadia Healthcare (ACHC) Rating Lowered to Hold at Deutsche Bank
www.americanbankingnews.com - April 5 at 2:58 PM |
| Acadia Healthcare (ACHC) Downgraded by Robert W. Baird to Neutral
www.americanbankingnews.com - April 5 at 2:58 PM |
| Bank of America Trims Acadia Healthcare (ACHC) Target Price to $52.00
www.americanbankingnews.com - April 5 at 12:39 PM |
| BioTelemetry (BEAT) versus Acadia Healthcare (ACHC) Critical Survey
www.americanbankingnews.com - April 5 at 5:35 AM |
| Acadia Healthcare (ACHC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 5 at 5:34 AM |
| Acadia Healthcare (ACHC) Given a $42.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 4 at 9:36 PM |
| Acadia Healthcare (ACHC) Price Target Cut to $48.00 by Analysts at BMO Capital Markets
www.americanbankingnews.com - April 4 at 7:58 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acadia Healthcare Company, Inc. (ACHC) & Lead Plaintiff Deadline: May 14, 2018
finance.yahoo.com - April 3 at 4:52 PM |
| AAC (AAC) versus Acadia Healthcare (ACHC) Head to Head Analysis
www.americanbankingnews.com - April 2 at 3:24 AM |
 | ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES ...
globenewswire.com - March 31 at 8:56 AM |
| ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
finance.yahoo.com - March 31 at 8:56 AM |
| Investors Buy High Volume of Put Options on Acadia Healthcare (ACHC)
www.americanbankingnews.com - March 30 at 7:14 AM |
| Acadia Healthcare (ACHC) Expected to Announce Quarterly Sales of $730.01 Million
www.americanbankingnews.com - March 30 at 2:26 AM |
| INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Acadia Healthcare Company, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
finance.yahoo.com - March 29 at 4:50 PM |
| Acadia Healthcare (ACHC) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - March 29 at 4:44 PM |
| Investors Purchase Large Volume of Call Options on Acadia Healthcare (ACHC)
www.americanbankingnews.com - March 29 at 6:45 AM |
| Brokerages Anticipate Acadia Healthcare (ACHC) to Post $0.47 Earnings Per Share
www.americanbankingnews.com - March 28 at 5:28 PM |
| Specialized Health Services Stocks' Research Reports Released on Acadia Healthcare, DaVita, MEDNAX, and Tivity Health
www.bizjournals.com - March 28 at 9:15 AM |
| The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Acadia Healthcare Company, Inc. (ACHC)
finance.yahoo.com - March 27 at 9:22 AM |
| Acadia Healthcare (ACHC) Earns Outperform Rating from Analysts at Wells Fargo
www.americanbankingnews.com - March 26 at 3:42 PM |
 | Bernstein Liebhard LLP Announces That A Class Action Has Been Filed On Behalf Of Acadia Healthcare Company, Inc. Investors
www.prnewswire.com - March 26 at 12:02 PM |
 | ACADIA HEALTHCARE COMPANY INC
www.finanznachrichten.de - March 24 at 9:32 AM |
| Acadia Healthcare (ACHC) Up 14.2% Since Earnings Report: Can It Continue?
www.zacks.com - March 24 at 9:32 AM |
| The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Acadia Healthcare Company, Inc.
finance.yahoo.com - March 23 at 4:56 PM |
| INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible ... - Business Wire (press release)
www.businesswire.com - March 21 at 5:02 PM |
| Acadia Healthcare Company, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible ... - Business Wire (press release)
www.businesswire.com - March 21 at 5:02 PM |
| ACHC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving ... - Business Wire (press release)
www.businesswire.com - March 21 at 9:59 AM |
 | Is Acadia Healthcare (ACHC) a Great Stock for Value Investors Right Now? - Nasdaq
www.nasdaq.com - March 20 at 4:43 PM |
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Acadia Healthcare Company, Inc. (Nasdaq:ACHC) To Contact Brower Piven Before The Lead Plaintiff Deadline
finance.yahoo.com - March 20 at 9:15 AM |
| INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Acadia Healthcare Company, Inc.
finance.yahoo.com - March 20 at 9:15 AM |
Acadia Healthcare (NASDAQ:ACHC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Acadia Healthcare (NASDAQ:ACHC) Income Statement, Balance Sheet and Cash Flow Statement
Acadia Healthcare (NASDAQ ACHC) Stock Chart for Thursday, April, 19, 2018
Loading chart…
